Alerts will be sent to your verified email
Verify EmailSAKAR
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sakar Healthcare, an Indian pharmaceutical company, manufactures and markets a wide range of pharmaceutical formulations for domestic and international markets. It also provides contract manufacturing services for pharmaceutical companies in India.
Sakar Healthcare major competitors are Gufic Biosciences, Caplin Point Lab, Ind-Swift Lab., Jagsonpal Pharma, Kwality Pharma, Lincoln Pharma, Fredun Pharma.
Market Cap of Sakar Healthcare is ₹1,032 Crs.
While the median market cap of its peers are ₹1,180 Crs.
Sakar Healthcare seems to be less financially stable compared to its competitors.
Altman Z score of Sakar Healthcare is 6.35 and is ranked 4 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | Sep | ||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|